In vitro activity of tigecycline and molecular characterization of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates from a university hospital in south-western Germany

scientific article published on 25 July 2012

In vitro activity of tigecycline and molecular characterization of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates from a university hospital in south-western Germany is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1159/000339488
P8608Fatcat IDrelease_2ygivsntgfbj7b2mpobhx2lwny
P698PubMed publication ID22832033

P2093author name stringIngo B Autenrieth
Sabine Gröbner
Yvonne Pfeifer
Matthias Marschal
Patrick Weissgerber
Matthias Wienke
P2860cites workConjugative IncFI plasmids carrying CTX-M-15 among Escherichia coli ESBL producing isolates at a University hospital in GermanyQ33469945
Spread of Escherichia coli strains with high-level cefotaxime and ceftazidime resistance between the community, long-term care facilities, and hospital institutionsQ34720052
CTX-M-type extended-spectrum beta-lactamases in Italy: molecular epidemiology of an emerging countrywide problemQ34973754
Identifying patients harboring extended-spectrum-beta-lactamase-producing Enterobacteriaceae on hospital admission: derivation and validation of a scoring systemQ35065875
Bloodstream infections caused by extended-spectrum-beta-lactamase- producing Escherichia coli: risk factors for inadequate initial antimicrobial therapyQ36870786
Antibiotic policy and prescribing strategies for therapy of extended-spectrum beta-lactamase-producing Enterobacteriaceae: the role of piperacillin-tazobactamQ37043641
Dramatic increase in prevalence of fecal carriage of extended-spectrum beta-lactamase-producing Enterobacteriaceae during nonoutbreak situations in SpainQ37576488
Molecular epidemiology of Escherichia coli producing CTX-M beta-lactamases: the worldwide emergence of clone ST131 O25:H4.Q37671098
Extended-spectrum [beta]-lactamase producing Escherichia coli: changing epidemiology and clinical impactQ37770996
Emerging resistant Gram-negative aerobic bacilli in hospital-acquired infectionsQ37811723
Emergence of carbapenem-non-susceptible extended-spectrum beta-lactamase-producing Klebsiella pneumoniae isolates at the university hospital of Tübingen, GermanyQ39973074
Nationwide survey of extended-spectrum {beta}-lactamase-producing Enterobacteriaceae in the French community settingQ39991540
Role of beta-lactamases and porins in resistance to ertapenem and other beta-lactams in Klebsiella pneumoniaeQ41269079
Characterization and sequence analysis of extended-spectrum-{beta}-lactamase-encoding genes from Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis isolates collected during tigecycline phase 3 clinical trialsQ41813766
High levels of antimicrobial coresistance among extended-spectrum-beta-lactamase-producing Enterobacteriaceae.Q42054872
Influence of transcriptional activator RamA on expression of multidrug efflux pump AcrAB and tigecycline susceptibility in Klebsiella pneumoniaeQ42165204
Antibiotic coresistance in extended-spectrum-beta-lactamase-producing Enterobacteriaceae and in vitro activity of tigecyclineQ42549433
Detection of extended-spectrum beta-lactamases among Enterobacteriaceae by use of semiautomated microbiology systems and manual detection proceduresQ42799124
Salmonella enterica serovar Typhi with CTX-M beta-lactamase, GermanyQ42919287
Susceptibility of common aerobic pathogens to tigecycline: results of a surveillance study in GermanyQ43732434
Collateral damage of flomoxef therapy: in vivo development of porin deficiency and acquisition of blaDHA-1 leading to ertapenem resistance in a clinical isolate of Klebsiella pneumoniae producing CTX-M-3 and SHV-5 beta-lactamasesQ44706480
Virulence characteristics and phylogenetic background of multidrug-resistant and antimicrobial-susceptible clinical isolates of Escherichia coli from across the United States, 2000-2001.Q45119838
Prevalence and antimicrobial resistance patterns of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolated from blood cultures in an Istanbul University Hospital.Q45972088
Comparative in vitro activity of tigecycline against enterobacteria producing two or more extended-spectrum beta-lactamasesQ46369724
Tigecycline in vitro activity against gram-negative and gram-positive pathogens collected in ItalyQ46855384
Molecular epidemiology of fluoroquinolone-resistant ST131 Escherichia coli producing CTX-M extended-spectrum beta-lactamases in nursing homes in Belfast, UK.Q47598652
Molecular epidemiology of Escherichia coli producing extended-spectrum {beta}-lactamases in Lugo (Spain): dissemination of clone O25b:H4-ST131 producing CTX-M-15.Q48070401
Prospective, non-interventional, multi-centre trial of tigecycline in the treatment of severely ill patients with complicated infections: new insights into clinical results and treatment practice.Q54356662
Faecal carriage of extended-spectrum beta-lactamase-producing Escherichia coli: prevalence, risk factors and molecular epidemiology.Q54419391
Plasmid comparison and molecular analysis of Klebsiella pneumoniae harbouring blaKPC from New York City and TorontoQ59187044
P433issue3
P921main subjectGermanyQ183
Escherichia coliQ25419
Klebsiella pneumoniaeQ132592
P304page(s)241-248
P577publication date2012-07-25
P1433published inChemotherapyQ2440355
P1476titleIn vitro activity of tigecycline and molecular characterization of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates from a university hospital in south-western Germany
P478volume58

Reverse relations

Q38074212Evolution of antimicrobial resistance among Enterobacteriaceae (focus on extended spectrum β-lactamases and carbapenemases).cites workP2860

Search more.